IL24946A - Process for preparing antibodies in cilus pertussis - Google Patents
Process for preparing antibodies in cilus pertussisInfo
- Publication number
- IL24946A IL24946A IL2494666A IL2494666A IL24946A IL 24946 A IL24946 A IL 24946A IL 2494666 A IL2494666 A IL 2494666A IL 2494666 A IL2494666 A IL 2494666A IL 24946 A IL24946 A IL 24946A
- Authority
- IL
- Israel
- Prior art keywords
- pertussis
- cell wall
- wall material
- protective
- antigen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42669165A | 1965-01-19 | 1965-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL24946A true IL24946A (en) | 1969-05-28 |
Family
ID=23691819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL2494666A IL24946A (en) | 1965-01-19 | 1966-01-10 | Process for preparing antibodies in cilus pertussis |
Country Status (11)
Country | Link |
---|---|
BE (1) | BE675310A (hr) |
BR (1) | BR6676474D0 (hr) |
DE (1) | DE1617605C3 (hr) |
DK (1) | DK115720B (hr) |
ES (1) | ES322331A1 (hr) |
FR (2) | FR1475742A (hr) |
GB (1) | GB1119543A (hr) |
IL (1) | IL24946A (hr) |
NL (1) | NL6600703A (hr) |
NO (1) | NO116869B (hr) |
SE (1) | SE326797B (hr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ188211A (en) * | 1977-10-28 | 1984-09-28 | American Cyanamid Co | Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens |
DE3043291A1 (de) * | 1980-11-17 | 1982-07-01 | Dso Pharmachim | Vakzine gegen keuchhusten |
US4474758A (en) * | 1981-11-19 | 1984-10-02 | American Cyanamid Company | Haemophilus influenzae type b and pertussis outer membrane component combined vaccine |
WO1998054987A1 (en) * | 1997-06-04 | 1998-12-10 | Cellular Improvements Ltd | Method and apparatus for disruption of biological material |
-
1966
- 1966-01-10 NO NO16118766A patent/NO116869B/no unknown
- 1966-01-10 IL IL2494666A patent/IL24946A/en unknown
- 1966-01-12 GB GB150466A patent/GB1119543A/en not_active Expired
- 1966-01-17 BR BR17647466A patent/BR6676474D0/pt unknown
- 1966-01-18 DK DK26066A patent/DK115720B/da unknown
- 1966-01-18 FR FR46281A patent/FR1475742A/fr not_active Expired
- 1966-01-18 SE SE00630/66A patent/SE326797B/xx unknown
- 1966-01-18 DE DE19661617605 patent/DE1617605C3/de not_active Expired
- 1966-01-18 ES ES0322331A patent/ES322331A1/es not_active Expired
- 1966-01-19 BE BE675310D patent/BE675310A/xx unknown
- 1966-01-19 NL NL6600703A patent/NL6600703A/xx unknown
- 1966-04-15 FR FR57878A patent/FR5550M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NL6600703A (hr) | 1966-07-20 |
FR1475742A (fr) | 1967-04-07 |
NO116869B (hr) | 1969-06-02 |
DE1617605C3 (de) | 1974-08-29 |
DE1617605A1 (de) | 1971-04-01 |
GB1119543A (en) | 1968-07-10 |
ES322331A1 (es) | 1966-11-16 |
SE326797B (hr) | 1970-08-03 |
BR6676474D0 (pt) | 1973-09-11 |
BE675310A (hr) | 1966-07-19 |
DK115720B (da) | 1969-11-03 |
DE1617605B2 (de) | 1974-01-31 |
FR5550M (hr) | 1967-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4197290A (en) | Vaccine | |
Punsalang Jr et al. | Role of pili in the virulence of Neisseria gonorrhoeae | |
Baker et al. | Studies on immunization against plague: I. The isolation and characterization of the soluble antigen of Pasteurella pestis | |
GP | Immunity to anthrax: protective antigen present in cell-free culture filtrates. | |
US3395219A (en) | Process for production of pertussis antigen | |
MacLeod et al. | Stepwise intratype transformation of pneumococcus from R to S by way of a variant intermediate in capsular polysaccharide production | |
CA1154382A (en) | Vaccine and method of making | |
US4311797A (en) | Anucleated live E. coli vaccine | |
HU185404B (en) | Process for preparing pertussis toxoide | |
EP0041897B1 (en) | Polysaccharide antigen from streptococcus and vaccines | |
Agius et al. | Immunization of rainbow trout, Salmo gairdneri Richardson, against vibriosis: comparison of an extract antigen with whole cell bacterins by oral and intraperitoneal routes | |
Watson et al. | Studies on Infection with Bacillus anthracis: III. Chemical and Immunological Properties of the Protective Antigen in Crude Extracts of Skin Lesions of B. anthraci | |
WO1993021951A1 (en) | Method for producing a bacterial vaccine and novel vaccines produced thereby | |
WO1979000823A1 (en) | Neisseria gonorrhoeae vaccine | |
Kusuda et al. | The efficacy of attenuated live bacterin of Pusteurella piscicids against pseudotuberculosis in yellowtail | |
IL24946A (en) | Process for preparing antibodies in cilus pertussis | |
US4367222A (en) | Immune globulin specific to Group B streptococci | |
Lynn et al. | Immunoprotective activity of ribosomes from Haemophilus influenzae | |
US3465078A (en) | Method of recovering antigens from bordetella pertussis cells | |
US3141824A (en) | Pertussis antigen | |
US4367223A (en) | Vaccine against Group B streptococci | |
US4356263A (en) | Method of making a polysaccharide vaccine | |
US4367221A (en) | Immunization against Group B streptococci | |
Hanson et al. | Immunization of mice with irradiated Trypanosoma cruzi grown in cell culture: Relation of numbers of parasites, immunizing injections, and route of immunization to resistance | |
Youmans et al. | Further studies on a labile immunogenic particulate substance isolated from Mycobacterium tuberculosis |